These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22783238)

  • 1. Hydroxyurea treatment inhibits proliferation of Cryptococcus neoformans in mice.
    Tripathi K; Mor V; Bairwa NK; Del Poeta M; Mohanty BK
    Front Microbiol; 2012; 3():187. PubMed ID: 22783238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular morphogenesis under stress is influenced by the sphingolipid pathway gene ISC1 and DNA integrity checkpoint genes in Saccharomyces cerevisiae.
    Tripathi K; Matmati N; Zheng WJ; Hannun YA; Mohanty BK
    Genetics; 2011 Oct; 189(2):533-47. PubMed ID: 21840863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea sensitivity reveals a role for ISC1 in the regulation of G2/M.
    Matmati N; Kitagaki H; Montefusco D; Mohanty BK; Hannun YA
    J Biol Chem; 2009 Mar; 284(13):8241-6. PubMed ID: 19158081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of C18:1-phytoceramide as the candidate lipid mediator for hydroxyurea resistance in yeast.
    Matmati N; Metelli A; Tripathi K; Yan S; Mohanty BK; Hannun YA
    J Biol Chem; 2013 Jun; 288(24):17272-84. PubMed ID: 23620586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system.
    Shea JM; Kechichian TB; Luberto C; Del Poeta M
    Infect Immun; 2006 Oct; 74(10):5977-88. PubMed ID: 16988277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.
    Aaron PA; Vu K; Gelli A
    mBio; 2020 Jul; 11(4):. PubMed ID: 32694141
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of inositol phospho-sphingolipid-phospholipase C 1 (Isc1) in Cryptococcus neoformans reveals unique biochemical features.
    Henry J; Guillotte A; Luberto C; Del Poeta M
    FEBS Lett; 2011 Feb; 585(4):635-40. PubMed ID: 21256847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles for de novo versus hydrolytic pathways of sphingolipid biosynthesis in Saccharomyces cerevisiae.
    Cowart LA; Okamoto Y; Lu X; Hannun YA
    Biochem J; 2006 Feb; 393(Pt 3):733-40. PubMed ID: 16201964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol phosphosphingolipid phospholipase C1 regulates plasma membrane ATPase (Pma1) stability in Cryptococcus neoformans.
    Farnoud AM; Mor V; Singh A; Del Poeta M
    FEBS Lett; 2014 Nov; 588(21):3932-8. PubMed ID: 25240197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.
    Singh A; Wang H; Silva LC; Na C; Prieto M; Futerman AH; Luberto C; Del Poeta M
    Cell Microbiol; 2012 Apr; 14(4):500-16. PubMed ID: 22151739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
    Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
    mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
    Matmati N; Hannun YA
    J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
    Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
    mBio; 2016 May; 7(3):. PubMed ID: 27165801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae.
    Sawai H; Okamoto Y; Luberto C; Mao C; Bielawska A; Domae N; Hannun YA
    J Biol Chem; 2000 Dec; 275(50):39793-8. PubMed ID: 11006294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea enhances post-fusion hyphal extension during sexual development in C. neoformans var. grubii.
    Zulkifli MN; Kaur JN; Panepinto JC
    Mycopathologia; 2012 Mar; 173(2-3):113-9. PubMed ID: 21952836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-dependent positive and negative functions of Fun30 chromatin remodeler in DNA damage response.
    Siler J; Xia B; Wong C; Kath M; Bi X
    DNA Repair (Amst); 2017 Feb; 50():61-70. PubMed ID: 28089177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISC1-encoded inositol phosphosphingolipid phospholipase C is involved in Na+/Li+ halotolerance of Saccharomyces cerevisiae.
    Betz C; Zajonc D; Moll M; Schweizer E
    Eur J Biochem; 2002 Aug; 269(16):4033-9. PubMed ID: 12180980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Transcription Factor Pdr802 Regulates Titan Cell Formation and Pathogenicity of Cryptococcus neoformans.
    Reuwsaat JCV; Agustinho DP; Motta H; Chang AL; Brown H; Brent MR; Kmetzsch L; Doering TL
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688010
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.